MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Topic
Monoclonal and Polyclonal Antibodies Research
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,236 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,236 works in the cohort · of 4,299,418page 37 of 45

Labels cover 5 of 2,236 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,236 of 2,236 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
NPA_ref5095
2019· article· en· Zenodo (CERN European Organization for Nuclear Research)· Medicine
machine prediction:candidate · insufficient_payloadconsensus · insufficient_payload
0
citations
affunlabeled
Reliable repurposing of antibody interactome inside the cell
Caitlin M. O’Shea, Rushba Shahzad, Kimia Aghasoleimani, Stuart A. Newman, Jiraporn Panmanee, Leonard C. Schalkwyk +9 more
2025· preprint· en· bioRxiv (Cold Spring Harbor Laboratory)· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
affunlabeled
Thymus-Independent Antigen
Douglas M. Templeton, Michael Schwenk, Reinhild Klein, John H. Duffus
2016· dataset· en· IUPAC Standards Online· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
affno abstractunlabeled
49* Probing the oligomeric state of CFTR
InSuk Joung, Yawar J. Qadri, Gergely L. Lukács, Bakhrom K. Berdiev
2011· article· en· Journal of Cystic Fibrosis· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
affunlabeled
Mastocytoma
Douglas M. Templeton, Michael Schwenk, Reinhild Klein, John H. Duffus
2016· dataset· en· IUPAC Standards Online· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
affno abstractunlabeled
TP011/#1536  A double-blind placebo-controlled phase III chemo-immunotherapy (Paclitaxel-carboplatin-oregovomab [PCO]) vs chemotherapy (Paclitaxel-carboplatin-placebo [PCP]) in patients with newly diagnosed, advanced epithelial ovarian cancer (EOC): FLORA-5/GOG-3035 study
Myong Cheol Lim, Yong‐Man Kim, Sunil Gupta, Srinivasa Rao Jada, Jung‐Yun Lee, Lucy Gilbert +8 more
2023· article· en· International Journal of Gynecological Cancer· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
fundno affunlabeled
Nat Biotechnol
2010· article· en· MPG.PuRe (Max Planck Society)· Medicine
machine prediction:candidate · insufficient_payloadconsensus · none
0
citations
affunlabeled
Antigen Processing
Douglas M. Templeton, Michael Schwenk, Reinhild Klein, John H. Duffus
2016· dataset· en· IUPAC Standards Online· Medicine
machine prediction:candidate · noneconsensus · none
0
citations

How this was built: Screen · Findings · About